P

Pharmx Technologies Ltd
ASX:PHX

Watchlist Manager
Pharmx Technologies Ltd
ASX:PHX
Watchlist
Price: 0.14 AUD 3.7% Market Closed
Market Cap: AU$83.9m

Balance Sheet

Balance Sheet Decomposition
Pharmx Technologies Ltd

Balance Sheet
Pharmx Technologies Ltd

Rotate your device to view
Balance Sheet
Currency: AUD
Jun-2001 Jun-2002 Jun-2003 Jun-2004 Jun-2005 Jun-2006 Jun-2007 Jun-2008 Jun-2009 Jun-2010 Jun-2011 Jun-2012 Jun-2013 Jun-2014 Jun-2015 Jun-2016 Jun-2017 Jun-2018 Jun-2019 Jun-2020 Jun-2021 Jun-2022 Jun-2023 Jun-2024
Assets
Cash & Cash Equivalents
0
2
0
2
2
4
4
1
1
0
0
0
0
0
1
10
8
5
2
2
6
6
13
13
Cash
0
2
0
2
2
4
4
1
1
0
0
0
0
0
1
0
0
0
0
0
0
1
0
1
Cash Equivalents
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
8
5
2
2
6
5
13
13
Short-Term Investments
0
0
0
0
0
0
0
0
0
1
2
3
9
12
11
0
0
0
0
0
0
5
13
0
Total Receivables
2
2
2
2
1
2
3
1
1
5
5
6
5
4
3
1
2
3
4
6
2
3
3
3
Accounts Receivables
1
2
1
2
1
2
3
1
1
1
0
0
0
0
0
0
0
2
2
4
1
1
1
1
Other Receivables
0
0
0
0
0
0
0
0
0
4
5
5
5
4
2
0
1
2
2
2
2
2
2
2
Inventory
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
1
0
0
0
1
4
4
0
0
0
0
0
0
2
2
3
3
2
1
0
7
0
Total Current Assets
3
4
3
5
3
6
8
7
5
6
7
9
14
16
15
13
12
11
9
10
10
9
23
16
PP&E Net
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
1
1
1
1
1
1
1
0
0
PP&E Gross
2
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
Accumulated Depreciation
1
2
2
2
2
2
3
4
5
5
5
5
5
4
3
0
0
0
0
0
0
2
0
0
Intangible Assets
8
2
2
0
0
1
3
3
3
2
1
0
0
0
0
11
5
7
4
5
19
19
11
11
Goodwill
12
6
5
5
4
15
15
15
11
11
11
11
11
11
11
0
0
0
0
0
0
2
2
2
Long-Term Investments
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
1
1
1
1
1
0
Other Assets
12
6
5
5
4
15
15
15
11
11
11
11
11
11
11
0
0
0
0
0
0
2
2
2
Total Assets
24
N/A
14
-42%
11
-21%
10
-5%
8
-22%
23
+188%
27
+16%
27
+1%
19
-30%
20
+4%
20
+0%
20
+2%
25
+25%
27
+8%
27
+0%
26
-4%
20
-24%
20
0%
15
-24%
19
+28%
31
+63%
31
-2%
37
+19%
30
-18%
Liabilities
Accounts Payable
6
8
11
11
7
3
5
7
9
3
3
3
2
2
3
5
4
4
4
4
5
3
1
2
Accrued Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
3
2
4
10
3
7
0
12
7
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
1
1
2
3
3
2
3
3
1
8
9
7
6
5
3
1
1
1
1
1
1
1
11
10
Total Current Liabilities
10
12
16
23
12
12
8
22
17
14
14
9
9
8
7
6
6
5
5
5
6
5
12
12
Long-Term Debt
1
0
1
0
7
7
11
0
0
3
1
0
0
0
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
Minority Interest
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
1
1
1
Total Liabilities
13
N/A
15
+15%
20
+34%
24
+21%
19
-22%
19
+3%
19
0%
22
+14%
17
-22%
17
-1%
15
-10%
10
-37%
9
-7%
8
-7%
7
-13%
6
-16%
6
-6%
5
-5%
5
0%
6
+9%
8
+41%
8
-10%
14
+89%
14
-3%
Equity
Common Stock
55
61
61
65
73
74
77
78
85
85
85
85
86
86
86
86
86
86
86
90
98
98
98
94
Retained Earnings
44
62
70
79
84
70
70
73
83
82
81
75
69
67
66
66
72
72
77
77
75
75
76
78
Total Equity
11
N/A
1
N/A
9
-770%
14
-51%
11
+21%
4
N/A
8
+98%
5
-32%
2
-60%
3
+44%
5
+60%
11
+130%
16
+53%
19
+15%
20
+6%
20
0%
14
-30%
14
+2%
10
-33%
13
+38%
23
+74%
23
+1%
22
-4%
16
-28%
Total Liabilities & Equity
24
N/A
14
-42%
11
-21%
10
-5%
8
-22%
23
+188%
27
+16%
27
+1%
19
-30%
20
+4%
20
+0%
20
+2%
25
+25%
27
+8%
27
+0%
26
-4%
20
-24%
20
0%
15
-24%
19
+28%
31
+63%
31
-2%
37
+19%
30
-18%
Shares Outstanding
Common Shares Outstanding
22
24
24
32
61
68
89
96
242
242
242
242
249
254
255
270
270
270
270
425
597
597
597
599